Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 27Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Neoplasm Metastasis 5Ovarian Neoplasms 4Neoplasms 3Multiple Myeloma 3Metastatic Castration-resistant Prostate Cancer 3Lymphoma, Non-Hodgkin 3Lymphoma 3Lymphoma, B-Cell 2Endometrial Neoplasms 2Breast Neoplasms 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomatitis 1Stomach Neoplasms 1Recurrence 1Prostate Cancer Metastatic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oral Ulcer 1Myasthenia Gravis 1Metastatic Castration-Resistant Prostate Cancer Patients 1Metastatic Castration-Resistant Prostate Cancer 1Hodgkin Disease 1Dendritic Cell Sarcoma, Interdigitating 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

enzalutamide 5abiraterone 3Prednisone 3Docetaxel 3Abiraterone Acetate 3relugolix 1pembrolizumab 1onvansertib 1olaparib 1lenvatinib 1inavolisib 1belzutifan 1apalutamide 1abemaciclib 1Prednisolone 1PF06821497 1Methylprednisolone 1Lutetium-177 1Lutetium 1Gonadotropin-Releasing Hormone 1Etoposide 1Dexamethasone 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Metastatic Castration-Resistant Prostate Cancer × Prednisolone × Clear all
NCT02405858 2025-02-03

A Study of Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer Participants Who Responded Poorly to the First-line Combined Androgen Blockade Therapy

Janssen Pharmaceutical K.K.

Phase 4 Completed
51 enrolled
Genitourinary

Metastatic Castration-Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡